Chronic Migraine

OnabotulinumtoxinA May Be Safe, Effective for Long-Term Headache Prevention in Chronic Migraine

OnabotulinumtoxinA May Be Safe, Effective for Long-Term Headache Prevention in Chronic Migraine

By

The use of onabotulinumtoxinA every 12 weeks over a 2-year period was found to be safe, and effective for headache prevention in patients with chronic migraine.

Stress Negatively Affects Acute Treatment for Chronic Migraine

Stress Negatively Affects Acute Treatment for Chronic Migraine

By

High levels of stress may be associated with poor acute treatment outcomes in patients with chronic migraine.

Factors Contributing to Improved Outcomes With OnabotulinumtoxinA for Chronic Migraine

Factors Contributing to Improved Outcomes With OnabotulinumtoxinA for Chronic Migraine

By

OnabotulinumtoxinA was shown to have a better outcome in patients with chronic migraine who start the treatment within 12 months of symptom onset.

High Headache Frequency Associated With Excessive Daytime Sleepiness

High Headache Frequency Associated With Excessive Daytime Sleepiness

By

An association was established between excessive daytime sleepiness and a high frequency of headaches.

Disability & Catastrophizing In Chronic Migraine vs Temporomandibular Disorder

Disability & Catastrophizing In Chronic Migraine vs Temporomandibular Disorder

By

Patients with chronic migraine share features with individuals with temporomandibular disorders that include kinesiophobia and neck disability.

Features of Patients With Chronic Migraine and Frequent Medication Overuse Relapse

Features of Patients With Chronic Migraine and Frequent Medication Overuse Relapse

By

In patients with chronic migraine and medication overuse, patients who frequently relapse into overuse following withdrawal have a worse clinical and psychological profile than patients who relapse less frequently.

Transcutaneous Supraorbital Neurostimulation as Prophylactic Treatment for Chronic Migraine

Transcutaneous Supraorbital Neurostimulation as Prophylactic Treatment for Chronic Migraine

By

Transcutaneous supraorbital neurostimulation provides an effective prophylactic treatment for patients with chronic migraine.

Hypothalamic Activation Greater in Chronic vs Episodic Migraine

Hypothalamic Activation Greater in Chronic vs Episodic Migraine

By

Examination of hypothalamic activity shows distinctly different patterns between episodic and chronic forms of migraine.

CBT Plus Amitriptyline Effective in Treating Chronic Migraine in Youth

CBT Plus Amitriptyline Effective in Treating Chronic Migraine in Youth

By

A combination of treatment with CBT and the tricyclic antidepressant amitriptyline led to greater improvements in youth with chronic migraine compared with treatment with headache education and amitriptyline.

Diagnosing and Treating Medication Overuse Headache

Diagnosing and Treating Medication Overuse Headache

Non-medication approaches such as biofeedback and cognitive behavioral therapy may be helpful adjunct therapies and may help with more long-term coping strategies.

Occipital Nerve Stimulation for Chronic Migraine

Occipital Nerve Stimulation for Chronic Migraine

Sixty and 35 percent of patients achieved a 30 and 50% reduction, respectively, in headache days and/or pain intensity.

Treatment With Monoclonal CGRP Antibody Reduces Number of Headache Hours

Treatment With Monoclonal CGRP Antibody Reduces Number of Headache Hours

By

Participants experienced a reduction in headache days as soon as 3 days post-treatment.

Cryoanalgesia to Treat Chronic Daily Headaches and Migraines

Cryoanalgesia to Treat Chronic Daily Headaches and Migraines

By

Cryoanalgesia for chronic headaches: easy to use, reversible

Sign Up for Free e-Newsletters